CCL2 and neoplasm: Recently, CREBBP LOF has also been proposed to increase the expression of CSF1 and CCL2 in DLBCL tumor cells, thereby promoting tumor-associated macrophage recruitment and polarization towards immunosuppressive macrophages (90).